Overview
Description
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of non-antibiotic anti-infective consumer products. It primarily operates in the field of eye care under the proprietary name Avenova®, which is a lid and lash hygiene product designed to maintain ocular health and comfort. The company places a strong emphasis on innovation within the pharmaceutical landscape, focusing on solutions that address prevalent health issues without relying on traditional antibiotics, thereby contributing to the significant global effort in combating antibiotic resistance. Operating in the healthcare sector, NovaBay Pharmaceuticals is pivotal in delivering effective consumer-friendly health solutions, catering to both the general public and healthcare professionals. Besides ophthalmology, its product lines also extend into dermatology, with offerings that provide relief and treatment for various skin conditions. Based in California, NovaBay Pharmaceuticals continues to enhance its market presence through strategic partnerships and direct consumer sales, reinforcing its commitment to improving health standards and responding dynamically to evolving medical needs.
About
CEO
Mr. Justin M. Hall Esq., J.D.
Employees
13
Address
2000 Powell Street
Suite 1150, eleventh floor
Emeryville, 94608, CA
United States
Suite 1150, eleventh floor
Emeryville, 94608, CA
United States
Phone
510 899 8800
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XASE